TargetProthrombin(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataKi: 0.100nMAssay Description:Binding affinity to human thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 0.310nMAssay Description:Inhibition of human Matrix metalloproteinase-9More data for this Ligand-Target Pair
TargetProthrombin(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataKi: 0.380nMAssay Description:Binding affinity to human thrombinMore data for this Ligand-Target Pair
TargetProthrombin(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataKi: 0.570nMAssay Description:Binding affinity to human thrombinMore data for this Ligand-Target Pair
TargetProthrombin(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataKi: 0.650nMAssay Description:Binding affinity to human thrombinMore data for this Ligand-Target Pair
TargetProthrombin(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataKi: 0.660nMAssay Description:Binding affinity to human thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 0.690nMAssay Description:Inhibition of human Matrix metalloproteinase-9More data for this Ligand-Target Pair
TargetProthrombin(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataKi: 0.700nMAssay Description:Inhibition of human thrombin after 15 mins by standard chromogenic assayMore data for this Ligand-Target Pair
TargetProthrombin(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataKi: 0.770nMAssay Description:Binding affinity to human thrombinMore data for this Ligand-Target Pair
TargetProthrombin(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataKi: 0.790nMAssay Description:Binding affinity to human thrombinMore data for this Ligand-Target Pair
TargetProthrombin(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataKi: 0.900nMAssay Description:Inhibition of human thrombin after 15 mins by standard chromogenic assayMore data for this Ligand-Target Pair
Affinity DataKi: <1nMAssay Description:Inhibition of human Matrix metalloproteinase-8More data for this Ligand-Target Pair
Affinity DataKi: <1nMAssay Description:Inhibition of human neutrophil collagenase, matrix metalloproteinase-8More data for this Ligand-Target Pair
Affinity DataKi: <1nMAssay Description:Inhibition of human Matrix metalloproteinase-8More data for this Ligand-Target Pair
Affinity DataKi: 1.20nMAssay Description:Inhibition of human Matrix metalloproteinase-9More data for this Ligand-Target Pair
TargetProthrombin(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataKi: 1.20nMAssay Description:Binding affinity to human thrombinMore data for this Ligand-Target Pair
TargetProthrombin(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataKi: 1.20nMAssay Description:Binding affinity to human thrombinMore data for this Ligand-Target Pair
TargetProthrombin(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataKi: 1.30nMAssay Description:Binding affinity to human thrombinMore data for this Ligand-Target Pair
TargetProthrombin(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataKi: 1.30nMAssay Description:Inhibition of human alpha-thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 1.30nMAssay Description:Inhibition of human Matrix metalloproteinase-9More data for this Ligand-Target Pair
TargetProthrombin(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataKi: 1.30nMAssay Description:Inhibitory constant against human alpha thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 1.40nMAssay Description:Inhibition of human Matrix metalloproteinase-9More data for this Ligand-Target Pair
TargetProthrombin(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataKi: 1.70nMAssay Description:Binding affinity to human thrombinMore data for this Ligand-Target Pair
TargetProthrombin(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataKi: 1.70nMAssay Description:Inhibition of human alpha-thrombinMore data for this Ligand-Target Pair
TargetProthrombin(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataKi: 1.80nMAssay Description:Binding affinity to human thrombinMore data for this Ligand-Target Pair
TargetProthrombin(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataKi: 1.80nMAssay Description:Inhibition of human thrombin after 15 mins by standard chromogenic assayMore data for this Ligand-Target Pair
Affinity DataKi: 2nMAssay Description:Inhibition of human neutrophil collagenase(HNC), MMP-8More data for this Ligand-Target Pair
Affinity DataKi: 2nMAssay Description:Inhibition of human neutrophil collagenase(HNC), MMP-8More data for this Ligand-Target Pair
Affinity DataKi: 2nMAssay Description:Inhibition of human neutrophil collagenase(HNC), MMP-8More data for this Ligand-Target Pair
Affinity DataKi: <2nMAssay Description:Inhibition of human Matrix metalloproteinase-8More data for this Ligand-Target Pair
Affinity DataKi: <2nMAssay Description:Inhibition of human Matrix metalloproteinase-8More data for this Ligand-Target Pair
Affinity DataKi: <2nMAssay Description:Inhibition of human Matrix metalloproteinase-8More data for this Ligand-Target Pair
Affinity DataKi: <2nMAssay Description:Inhibition of human Matrix metalloproteinase-8More data for this Ligand-Target Pair
Affinity DataKi: 2nMAssay Description:Inhibition of human neutrophil collagenase, matrix metalloproteinase-8More data for this Ligand-Target Pair
Affinity DataKi: 2nMAssay Description:Inhibitory concentration of compound against human fibroblast stromelysin (HFS) was determinedMore data for this Ligand-Target Pair
Affinity DataKi: 2nMAssay Description:Inhibition of human fibroblast collagenase, matrix metalloproteinase-1More data for this Ligand-Target Pair
TargetStromelysin-1(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataKi: 2nMAssay Description:Inhibitory potency against human stromelysin, MMP-3More data for this Ligand-Target Pair
Affinity DataKi: 2nMAssay Description:Inhibition of human neutrophil collagenase(HNC), MMP-8More data for this Ligand-Target Pair
Affinity DataKi: <2nMAssay Description:Inhibition of human neutrophil collagenase, matrix metalloproteinase-8More data for this Ligand-Target Pair
Affinity DataKi: <2nMAssay Description:Inhibition of human neutrophil collagenase, matrix metalloproteinase-8More data for this Ligand-Target Pair
TargetProthrombin(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataKi: 2.10nMAssay Description:Inhibitory activity of the compound was tested against alpha-human thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 2.20nM ΔG°: -49.4kJ/molepH: 7.4 T: 2°CAssay Description:The progress of DPPIV inhibition by compounds was measured by recording the liberation of free pNA at 405 nm. IC50 was determined from the slope of r...More data for this Ligand-Target Pair
TargetProthrombin(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataKi: 2.30nMAssay Description:Inhibition of human alpha-thrombinMore data for this Ligand-Target Pair
TargetProthrombin(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataKi: 2.30nMAssay Description:Binding affinity to human thrombinMore data for this Ligand-Target Pair
TargetProthrombin(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataKi: 2.70nMAssay Description:Inhibition of human thrombin after 15 mins by standard chromogenic assayMore data for this Ligand-Target Pair
TargetProthrombin(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataKi: 2.80nMAssay Description:Inhibition of human thrombin after 15 mins by standard chromogenic assayMore data for this Ligand-Target Pair
TargetProthrombin(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataKi: 2.90nMAssay Description:Binding affinity to human thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 3nMAssay Description:Inhibitory potency against human fibroblast collagenase, MMP-1More data for this Ligand-Target Pair
TargetStromelysin-1(Homo sapiens (Human))
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Sterling Winthrop Pharmaceuticals Research Division
Curated by ChEMBL
Affinity DataKi: 3nMAssay Description:Inhibitory potency against human stromelysin, MMP-3More data for this Ligand-Target Pair
Affinity DataKi: 3.10nM ΔG°: -48.6kJ/molepH: 7.4 T: 2°CAssay Description:The progress of DPPIV inhibition by compounds was measured by recording the liberation of free pNA at 405 nm. IC50 was determined from the slope of r...More data for this Ligand-Target Pair